Biomedical research

Clinical research
#Biomedical research #Drug discovery #Drug repurposing #LifeArc #Medical Research Council #Medicines repurposing

Toolkit launched for medicines repurposing

A free online toolkit has been launched to help researchers navigate the opportunities and challenges of repurposing medicines for different indications. The toolkit was created by medical research charity LifeArc and the Medical Research Council (MRC). “Having learned the challenges of repurposing firsthand, I think this toolkit is enormously practical… Read More

#News

Kanekwa Zyambo and Dr Morrison
#Biomedical research #Gut microbiome #Sub-Saharan Africa #University of Glasgow #University of Zambia

Scottish and Zambian researchers tackle environmental enteropathy

Scottish scientists are teaming up with researchers from Zambia to find new ways to diagnose and treat a condition which affects millions in Sub-Saharan Africa.   Ms Kanekwa Zyambo, from the University of Zambia, is spending two weeks at the Scottish Universities Environmental Research Centre in East Kilbride to… Read More

#News

Vials for medical research
#Antibodies #Biomedical research #Drug development #Drug discovery #In vitro

New anti-evolocumab antibodies could aid drug development

Bio-Rad Laboratories has introduced a range of type 1 antibodies that inhibit the binding of evolocumab (Repatha) to its target, human proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that has been shown to play a key role in the regulation of cholesterol levels.  These sequence-defined, recombinant antibodies are… Read More

#News

Diabetes patient injecting insulin
#Autoimmune disease #Biomedical research #Cardiovascular disease #Diabetes #Statins #Type 2 diabetes

Study: autoimmune disorders increase cardiovascular risk

Individuals with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease, a large epidemiological study has revealed.  The research – led by KU Leuven in collaboration with colleagues in the UK, including the University of Glasgow, and published in The Lancet – shows for the first… Read More

#News

#Biomedical research #Cancer #Cannabinoid #Oncology #Plant-based

Can cannabis and mushroom-based products eliminate colon cancer cells?

Cannabotech, a biomedical company developing oncological products based on cannabis and mushroom extracts, reports cell model study results showing that its ‘integrative-colon’ products killed over 90% of colon cancer cells. These products are based on a combination of several cannabinoids from the cannabis plant and various mushroom extracts. The study… Read More

#Cancer Research #Editor's Choice #News #Trending News

#Biomedical research #Data #Research

Spotlight: Tackling the issue of scientific data waste 

More than half of all scientific research is irreproducible, and more than 80% of scientific research data is being lost within 20 years. In the biomedical field alone, irreproducible research costs the industry £28 billion (US$38 billion) every year. Megan Thomas talks to Founder of Labstep Jake Schofield, about this issue.  MT:… Read More

#Business & Investment #Editor's Choice #Exclusive Content #Intelligence #News #Opinion #Start-up Zone #Trends & Analysis

#Biomedical research #Biotechnology #Immunology

Spatial biology imaging platform dedicated to skin

Genoskin, a biotechnology company using live ex vivo human skin to test therapeutic and non-therapeutic products, has launched Mantis, a new spatial biology imaging platform dedicated to skin immunology. This new offer was developed by Genoskin’s recently appointed CSO Dr. Nicolas Gaudenzio and his team at Inserm.   What is Mantis?  … Read More

#News

#Biomedical research

Sino Biological featured on Worldwide Business 

Dr Rob Burgess, Chief Business Officer for Sino Biological, has been interviewed on Worldwide Business with Kathy Ireland. This television series examines companies around the world currently impacting different sectors of business and society.   “I’m delighted with the chance to outline the company’s global impact on human… Read More

#News

#Biomedical research #Biomedicine #Cell culture #Collaboration #Software

Collaboration offers high throughput 3D cell screening solution 

UPM Biomedicals has entered into an agreement with PerkinElmer to act as a distributor of the UPM GrowDex and GrowDase range of products. This new collaboration will offer researchers a complete solution for high throughput screening (HTS) of 3D cell cultures in early drug discovery, combining PerkinElmer’s cell imaging and automation solutions and… Read More

#News

#Bioinformatics #Biomedical research #Neurodegenerative disorders #Neuroscience #Research

Novel research identifies gene targets of stress hormones in the brain

New research has moved a step forward in understanding how glucocorticoid hormones (‘stress hormones’) act upon the brain and what their function is. The findings could lead to more effective strategies in the prevention and treatment of mental health disorders. The study, led by academics at the University of Bristol… Read More

#News #Trending News

#Biomedical research #Drug discovery #Life sciences

£1 million grant will help develop new medicines in Scotland

The University of Dundee has received £1 million from the Wolfson Foundation to contribute to the costs of fitting-out the Tay Cities Regional Innovation Hub with laboratories and facilities required by high-growth biomedical companies seeking to develop new medicines and medical technologies. The Innovation Hub is central to Growing the… Read More

#News

#Antibodies #AstraZeneca #Biomedical research #Covid-19 #Immunology / Virology & Vaccines #Pfizer #Vaccines

Covid antibody levels vary according to vaccine type

Two doses of the Oxford-AstraZeneca Covid-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains. These laboratory findings from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre are published… Read More

#Covid-19 #News #Trending News

#Antibiotics #Biomedical research #Drug discovery #Research

ANTRUK launches research grants programme for antibiotic resistance

Antibiotic Research UK (ANTRUK), a charity tackling bacterial antibiotic resistance, has launched its 2021 Small Research Grants / Career Development Awards scheme. This is the charity’s largest grants programme to date. The charity will be awarding one grant of up to £50,000 and six grants of up to £25,000 each. Read More

#News

#Biomedical research #Drug discovery #iPSC #Synthetic biology

Sitting down with…bit.bio

bit.bio is a synthetic biology company working on producing every human cell type at scale, with the aim of transforming the research and medicine landscape. Farah Patell-Socha, PhD, VP Research Products tells Lu Rahman about some of the company’s groundbreaking work in this field and the benefits it is creating… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Biomedical research #Events #Life sciences #Toxicology

2021 Society of Toxicology ToxExpo

LifeNet Health LifeSciences, provider and collaborators in human in vitro biology and drug discovery optimisation, is highlighting innovative human cell and tissue-based research solutions at this year’s ToxExpo. The showcase includes the new, all-human Tri-Culture model, thyrocytes for use in 3D models and genotyped human hepatocytes. It can be found… Read More

#News